Detalhe da pesquisa
1.
Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer.
Eur J Cancer
; 198: 113480, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38154393